NIH Exploratory/Developmental Research Grant (R21)
The R21 funds early, high-risk ideas that could open a new direction, before there is enough data for an R01.
34 open NIH R21 calls right now →
What it funds
Exploratory or developmental work: a new model, method or technology, or a first test of an unconventional hypothesis. Preliminary data are not required, so reviewers judge the idea's promise and the soundness of the plan.
Who can apply
Same as the R01: any eligible institution may apply for any investigator. Not every NIH institute accepts R21s through the parent announcement, so check the participating institutes.
Award size
Up to $275,000 in direct costs across both years combined, with no more than $200,000 in a single year.
Duration
Up to 2 years. R21s cannot be renewed; the usual next step is an R01.
How applications are reviewed
Study-section review under the Simplified Review Framework, with the Research Strategy limited to 6 pages. Reviewers weigh potential impact against risk, and do not expect preliminary data.
Deadlines
Standard due dates for new applications are 16 February, 16 June and 16 October; resubmissions are due 16 March, 16 July and 16 November. Targeted NOFOs set their own dates.
Our summary, checked against NIH guidance in October 2026. Rules, budgets and dates change: always confirm in the current announcement before you apply.
Open NIH R21 calls
-
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of HealthUp to $200,000Deadline: November 17, 2026 ·
-
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: November 18, 2026 ·
-
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Centers for Disease Control and Prevention - ERAUp to $365,000Deadline: December 8, 2026 ·
-
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2027 ·
-
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2027 ·
-
NIOSH Exploratory/Developmental Grant Program (R21)
Centers for Disease Control and Prevention - ERAUp to $300,000Deadline: February 16, 2027 ·
-
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: May 7, 2027 ·
-
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: June 17, 2027 ·
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: July 2, 2027 ·
-
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institutes of HealthUp to $150,000Deadline: August 11, 2027 ·
-
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: September 7, 2027 ·
-
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: October 15, 2027 ·
-
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: October 16, 2027 ·
-
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: October 28, 2027 ·
-
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: November 16, 2027 ·
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
National Institutes of HealthUp to $200,000Deadline: November 16, 2027 ·
-
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: November 16, 2027 ·
-
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: December 3, 2027 ·
-
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
National Institutes of HealthUp to $200,000Deadline: January 7, 2028 ·
-
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
National Institutes of HealthUp to $200,000Deadline: January 7, 2028 ·
-
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
-
Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health$190,000 – $500,000Deadline: February 16, 2028 ·
-
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: February 17, 2028 ·
-
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
National Institutes of HealthUp to $200,000Deadline: June 15, 2028 ·
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: July 20, 2028 ·
-
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of HealthNot specifiedDeadline: September 7, 2028 ·
-
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
National Institutes of HealthUp to $200,000Deadline: October 20, 2028 ·
Writing guides
- How to write NIH Specific Aims: what funded applications do
- The structure of a fundable research abstract
Get matched with NIH R21 calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free